DK0958816T3 - Lægemiddel til behandling af diabetes mellitus såvel som dens fölgesygdomme - Google Patents
Lægemiddel til behandling af diabetes mellitus såvel som dens fölgesygdommeInfo
- Publication number
- DK0958816T3 DK0958816T3 DK99102285T DK99102285T DK0958816T3 DK 0958816 T3 DK0958816 T3 DK 0958816T3 DK 99102285 T DK99102285 T DK 99102285T DK 99102285 T DK99102285 T DK 99102285T DK 0958816 T3 DK0958816 T3 DK 0958816T3
- Authority
- DK
- Denmark
- Prior art keywords
- diabetes mellitus
- sequelae
- medicaments
- drug
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4343593A DE4343593C2 (de) | 1993-12-21 | 1993-12-21 | Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz |
EP94120045A EP0659408B1 (de) | 1993-12-21 | 1994-12-17 | Verwendung von R-(+)alpha-Liponsäure, R(-)-Dihydroliponsäure und Metabolite zur Behandlung von Diabetes mellitus sowie seiner Folgeerkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0958816T3 true DK0958816T3 (da) | 2006-07-17 |
Family
ID=6505606
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94120045T DK0659408T3 (da) | 1993-12-21 | 1994-12-17 | Anvendelse af R-(+)-alfa-liponsyre, R-(-)-dihydroliponsyre og metabolitter til behandling af diabetes mellitus og følgesygdomme deraf |
DK99102285T DK0958816T3 (da) | 1993-12-21 | 1994-12-17 | Lægemiddel til behandling af diabetes mellitus såvel som dens fölgesygdomme |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94120045T DK0659408T3 (da) | 1993-12-21 | 1994-12-17 | Anvendelse af R-(+)-alfa-liponsyre, R-(-)-dihydroliponsyre og metabolitter til behandling af diabetes mellitus og følgesygdomme deraf |
Country Status (11)
Country | Link |
---|---|
US (4) | US5693664A (da) |
EP (2) | EP0659408B1 (da) |
JP (1) | JPH07206676A (da) |
AT (2) | ATE203669T1 (da) |
CA (1) | CA2138558C (da) |
DE (3) | DE4343593C2 (da) |
DK (2) | DK0659408T3 (da) |
ES (2) | ES2159539T3 (da) |
GR (1) | GR3036943T3 (da) |
HK (1) | HK1023943A1 (da) |
PT (2) | PT659408E (da) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4343593C2 (de) * | 1993-12-21 | 1998-05-20 | Asta Medica Ag | Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz |
DE4433764A1 (de) * | 1994-09-22 | 1996-03-28 | Asta Medica Ag | Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit |
US6752999B2 (en) | 1995-09-20 | 2004-06-22 | Nicholas V. Perricone | Method of skin care and/or treatment using lipoic acid |
US7438896B2 (en) * | 1995-09-20 | 2008-10-21 | N.V. Perricone Llc | Method of skin care using lipoic and ascorbic acids |
WO1998023606A1 (fr) * | 1996-11-27 | 1998-06-04 | Fuji Kagaku Kogyo Kabushiki Kaisha | Derives dithio cycliques, remedes contre des maladies renales diabetiques, agents hypoglycemiques, agents hypolipidemiques et agents lenitifs contre les troubles digestifs |
EP0855396A1 (en) * | 1997-01-22 | 1998-07-29 | ASTA Medica Aktiengesellschaft | Thioctic acid metabolites and methods of use thereof |
DE19705555A1 (de) * | 1997-02-13 | 1998-08-20 | Ulrich Dr Posanski | Pharmazeutische Präparate der Thioctsäure zur oralen Anwendung |
IL123887A0 (en) | 1997-04-02 | 1998-10-30 | Sankyo Co | Dithiolan derivatives their use and pharmaceutical compositions containing the same |
US5965618A (en) * | 1997-11-17 | 1999-10-12 | Perricone; Nicholas V. | Treatment of scar tissue using lipoic acid |
US6365623B1 (en) | 1997-11-17 | 2002-04-02 | Nicholas V. Perricone | Treatment of acne using lipoic acid |
US6472432B1 (en) | 1997-11-17 | 2002-10-29 | Nicholas V. Perricone | Treatment of rosacea using lipoic acid |
DE19806354B4 (de) * | 1998-02-10 | 2004-09-16 | Bdd Group Holding Ag | Verwendung von α-Liponsäure oder deren physiologisch verträgliche Salze zur Behandlung von LDL-Hypercholesterinämie |
US6090842A (en) * | 1998-03-10 | 2000-07-18 | The Regents Of The University Of California | Lipoic acid analogs |
US6191162B1 (en) | 1998-05-28 | 2001-02-20 | Medical Research Institute | Method of reducing serum glucose levels |
US6197340B1 (en) * | 1998-05-28 | 2001-03-06 | Medical Research Institute | Controlled release lipoic acid |
US6905707B2 (en) * | 1998-05-28 | 2005-06-14 | Medical Research Institute | Controlled release arginine alpha ketoglutarate |
US20060024367A1 (en) * | 1998-05-28 | 2006-02-02 | Byrd Edward A | Controlled release alpha lipoic acid formulation with an inositol compound |
US20050085498A1 (en) * | 1998-05-28 | 2005-04-21 | Byrd Edward A. | Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate |
US20040259895A1 (en) * | 1998-05-28 | 2004-12-23 | Medical Research Institute | Oral formulation of lipid soluble thiamine and lipoic acid |
JP2000169371A (ja) * | 1998-10-02 | 2000-06-20 | Sankyo Co Ltd | ジチオラン誘導体を含有する医薬 |
US20010041187A1 (en) * | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
US6288106B1 (en) * | 1999-05-25 | 2001-09-11 | Chronorx, Llc | Processes for the synthesis and use of various α-lipoic acid complexes |
AU5725500A (en) * | 1999-06-02 | 2000-12-18 | Ashni Naturaceuticals, Inc. | A dietary supplement containing vanadyl sulfate, alpha-lipoic acid, and taurine |
DE19954321A1 (de) | 1999-11-11 | 2001-07-26 | Asta Medica Ag | Erleichterte Verabreichung von alpha-Liponsäure oder Derivaten derselben |
US6387945B2 (en) * | 2000-04-11 | 2002-05-14 | The Regents Of The University Of California | Lipoic acid analogs |
ATE320833T1 (de) * | 2000-06-06 | 2006-04-15 | Verwendung von einem liponsaüren -(r)- enantiomeren in kosmetika und dermatologie | |
EP1172110A3 (de) * | 2000-07-07 | 2003-09-17 | Basf Aktiengesellschaft | Verwendung von Liponsäure zur Verbesserung der Bioverfügbarkeit von Mineralsalzen |
DE10045059A1 (de) * | 2000-09-12 | 2002-03-21 | Basf Ag | Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen |
DE10048531C1 (de) * | 2000-09-30 | 2002-04-25 | Porsche Ag | Kühlluftführung für Kraftfahrzeuge |
WO2002044163A2 (de) | 2000-11-30 | 2002-06-06 | Basf Aktiengesellschaft | Verfahren zur herstellung von liponsäure und dihydroliponsaüre |
US6359075B1 (en) | 2001-01-09 | 2002-03-19 | Bridgestone/Firestone, Inc. | Means of producing high diblock content thermoplastic elastomers via chain transfer |
DE10113974B4 (de) * | 2001-03-22 | 2008-05-29 | Alzchem Trostberg Gmbh | Verwendung von racemischer und enantiomerenreiner Dihydroliponsäure oder deren Derivate zur Körpergewichtsreduzierung und/oder zur Verringerung des Appetits |
ES2327397T3 (es) * | 2001-04-30 | 2009-10-29 | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL | Esteres de uridina farmaceuticamente activos. |
DE10125882B4 (de) * | 2001-05-28 | 2007-03-29 | Esparma Gmbh | Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus |
DE10137381A1 (de) * | 2001-07-31 | 2003-02-13 | Viatris Gmbh | Neue Modifikationen des Trometamolsalzes der R-Thioctsäure sowie Verfahren zu ihrer Herstellung |
US20030144219A1 (en) | 2001-11-15 | 2003-07-31 | Phinney Stephen Dodge | Formulations and methods for treatment or amelioration of inflammatory conditions |
WO2003084532A1 (en) * | 2002-04-03 | 2003-10-16 | Avery Mitchell A | Lipoic acid analogs useful as provitamins and antioxidants |
US6733793B2 (en) | 2002-06-04 | 2004-05-11 | Metaproteomics, Llc | Oral composition with insulin-like activities and methods of use |
AU2003266287A1 (en) * | 2002-08-23 | 2004-03-11 | Dsm Ip Assets B.V. | Novel nutraceutical compositions comprising biotin |
JP4716666B2 (ja) * | 2003-05-21 | 2011-07-06 | 有限会社オガ リサーチ | α−リポ酸含有水性製剤 |
ITMI20032528A1 (it) * | 2003-12-19 | 2005-06-20 | Francesco Santangelo | Uso di cistina o di cisteina per la prevenzione e il |
WO2005095636A2 (en) * | 2004-03-24 | 2005-10-13 | Aveo Pharmaceuticals, Inc. | Methods for measuring enzyme activities in cells, blood, tumors and tissues |
DE102004050353A1 (de) * | 2004-10-15 | 2006-04-20 | Basf Ag | Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen |
WO2006042666A1 (de) * | 2004-10-18 | 2006-04-27 | Meda Pharma Gmbh & Co. Kg | R-(+)-α-LIPONSÄURE ZUR PRÄVENTION VON DIABETES |
US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
JP2006321732A (ja) * | 2005-05-18 | 2006-11-30 | Fancl Corp | 異常蛋白質除去及び8−ヒドロキシ2’−デオキシグアノシン増加抑制用組成物 |
US20070055070A1 (en) * | 2005-09-07 | 2007-03-08 | Lawrence Lowell J | Novel esters of lipoic acid |
US20070083054A1 (en) * | 2005-10-12 | 2007-04-12 | Lawrence Lowell J | Novel amides of lipoic acid |
US20070196442A1 (en) * | 2006-02-10 | 2007-08-23 | Heuer Marvin A | Method for improving the oral administration of alpha-lipoic acid |
US20070225354A1 (en) * | 2006-03-21 | 2007-09-27 | Eric Marchewitz | Use of dihydrolipoamide for enhancing physical performance |
JP2010520333A (ja) * | 2007-03-01 | 2010-06-10 | セダーズ−シナイ メディカル センター | 〔1,2〕−ジチオラン部分を含有する抗酸化剤重合体およびその使用 |
DE102007038849A1 (de) | 2007-08-16 | 2009-02-19 | Adscil Gmbh | Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie |
US20090054513A1 (en) * | 2007-08-22 | 2009-02-26 | Response Scientific, Inc. | Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease |
US7943163B2 (en) * | 2007-08-22 | 2011-05-17 | Response Scientific, Inc. | Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes |
US9028874B2 (en) * | 2008-01-03 | 2015-05-12 | Cedars-Sinai Medical Center | Antioxidant nanosphere comprising [1,2]-dithiolane moieties |
KR20110004846A (ko) * | 2008-03-04 | 2011-01-14 | 로버트 쇼어 | 효소의 구조, 활성 및/또는 발현 정도의 조절 |
DE202008005023U1 (de) | 2008-04-11 | 2008-07-17 | Day-Med-Concept Gmbh | Verwendung von α-Liponsäure und Coenzym Q10 zur selektiven Reduktion des visceralen Fettgewebes |
US8603531B2 (en) * | 2008-06-02 | 2013-12-10 | Cedars-Sinai Medical Center | Nanometer-sized prodrugs of NSAIDs |
US20100099751A1 (en) * | 2008-10-21 | 2010-04-22 | Al-Mulla Fahd | Method of treating diabetes-related vascular complications |
CN102245765B (zh) | 2008-10-21 | 2015-01-07 | 通用医院公司 | 细胞移植 |
EP2364304A1 (en) * | 2008-11-07 | 2011-09-14 | ISTITUTO BIOCHIMICO NAZIONALE SAVIO s.r.l. | Alpha-lipoic acid derivatives and their use in drug preparation |
WO2010060098A1 (en) | 2008-11-24 | 2010-05-27 | Cedars-Sinai Medical Center | Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof |
KR100935554B1 (ko) * | 2009-06-24 | 2010-01-07 | 주식회사 셀트리온제약 | 피페라진 다이티옥트산염 및 이를 포함하는 약제학적 조성물 |
KR101208955B1 (ko) * | 2010-06-01 | 2012-12-06 | 주식회사 셀트리온제약 | 피페라진 다이티옥트산염 및 글리메피리드를 포함하는 약제학적 조성물 |
CN103153376B (zh) | 2010-08-06 | 2018-04-20 | 通用医院公司以麻省总医院名义经营 | 用于细胞处理相关应用的系统和设备 |
WO2015001568A2 (en) * | 2013-07-01 | 2015-01-08 | Laurus Labs Private Limited | Sitagliptin lipoate salt, process for the preparation and pharmaceutical composition thereof |
FR3027228B1 (fr) * | 2014-10-20 | 2016-12-09 | Valbiotis | Composition comprenant un melange d'extraits vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique |
CN115536631B (zh) * | 2021-06-30 | 2024-01-30 | 江苏同禾药业有限公司 | 一种高纯度的右旋硫辛酸镁盐的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1213141B (it) * | 1984-02-17 | 1989-12-14 | Dobrivoje Tomic | Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche. |
DE4218572A1 (de) * | 1992-06-05 | 1993-12-09 | Asta Medica Ag | Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E |
DE4343593C2 (de) * | 1993-12-21 | 1998-05-20 | Asta Medica Ag | Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz |
-
1993
- 1993-12-21 DE DE4343593A patent/DE4343593C2/de not_active Expired - Fee Related
-
1994
- 1994-12-17 PT PT94120045T patent/PT659408E/pt unknown
- 1994-12-17 EP EP94120045A patent/EP0659408B1/de not_active Revoked
- 1994-12-17 AT AT94120045T patent/ATE203669T1/de not_active IP Right Cessation
- 1994-12-17 DE DE59410429T patent/DE59410429D1/de not_active Expired - Lifetime
- 1994-12-17 ES ES94120045T patent/ES2159539T3/es not_active Expired - Lifetime
- 1994-12-17 PT PT99102285T patent/PT958816E/pt unknown
- 1994-12-17 AT AT99102285T patent/ATE319444T1/de active
- 1994-12-17 DE DE59409810T patent/DE59409810D1/de not_active Revoked
- 1994-12-17 EP EP99102285A patent/EP0958816B1/de not_active Expired - Lifetime
- 1994-12-17 ES ES99102285T patent/ES2258302T3/es not_active Expired - Lifetime
- 1994-12-17 DK DK94120045T patent/DK0659408T3/da active
- 1994-12-17 DK DK99102285T patent/DK0958816T3/da active
- 1994-12-20 CA CA002138558A patent/CA2138558C/en not_active Expired - Fee Related
- 1994-12-21 JP JP6318836A patent/JPH07206676A/ja active Pending
- 1994-12-21 US US08/360,924 patent/US5693664A/en not_active Expired - Lifetime
-
1997
- 1997-06-19 US US08/878,843 patent/US5948810A/en not_active Expired - Lifetime
-
1999
- 1999-04-02 US US09/285,460 patent/US6117899A/en not_active Expired - Fee Related
-
2000
- 2000-05-24 HK HK00103082A patent/HK1023943A1/xx not_active IP Right Cessation
- 2000-07-28 US US09/628,295 patent/US6284787B1/en not_active Expired - Fee Related
-
2001
- 2001-10-18 GR GR20010401812T patent/GR3036943T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5948810A (en) | 1999-09-07 |
DE4343593C2 (de) | 1998-05-20 |
HK1023943A1 (en) | 2000-09-29 |
ES2258302T3 (es) | 2006-08-16 |
EP0659408B1 (de) | 2001-08-01 |
ES2159539T3 (es) | 2001-10-16 |
EP0958816A3 (de) | 1999-12-15 |
GR3036943T3 (en) | 2002-01-31 |
US5693664A (en) | 1997-12-02 |
PT659408E (pt) | 2001-12-28 |
DK0659408T3 (da) | 2001-10-01 |
EP0958816A2 (de) | 1999-11-24 |
EP0958816B1 (de) | 2006-03-08 |
PT958816E (pt) | 2006-06-30 |
DE4343593A1 (de) | 1995-06-22 |
US6117899A (en) | 2000-09-12 |
DE59410429D1 (de) | 2006-05-04 |
EP0659408A1 (de) | 1995-06-28 |
CA2138558A1 (en) | 1995-06-22 |
ATE319444T1 (de) | 2006-03-15 |
ATE203669T1 (de) | 2001-08-15 |
US6284787B1 (en) | 2001-09-04 |
CA2138558C (en) | 2009-02-10 |
DE59409810D1 (de) | 2001-09-06 |
JPH07206676A (ja) | 1995-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0958816T3 (da) | Lægemiddel til behandling af diabetes mellitus såvel som dens fölgesygdomme | |
IL87488A0 (en) | Pharmaceutical compositions for the topical treatment of conditions associated with photodamaged skin,comprising substituted propenyl phenyl derivatives | |
DE59010810D1 (de) | Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure | |
ES8802037A1 (es) | Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno | |
CA2097732A1 (en) | Composition comprising r-alpha-lipoic acid and vitamin e for treating diabetes mellitus | |
DE19375061I2 (de) | Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung. | |
DK0675717T3 (da) | Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin | |
ATE50493T1 (de) | Ibuprofen enthaltendes arzneimittel. | |
EP0334507A3 (en) | Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid | |
MY132432A (en) | Aromatic compounds | |
DE69719931T2 (de) | Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren | |
DE69009195D1 (de) | Isoxazol-Derivate mit Anti-Serotonin-Aktivität, deren Herstellungsverfahren und diese enthaltende Zusammensetzungen. | |
ES8700673A1 (es) | Un procedimiento para preparar derivados de acido griseolico | |
TW200420531A (en) | Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity | |
ES2156574B1 (es) | Nuevos derivados de tiazolidindiona como agentes antidiabeticos | |
DK0634396T3 (da) | Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer | |
ES2036560T3 (es) | Un metodo para preparar una composicion sinergicamente activa para el tratamiento de hipertension. | |
DK0378146T3 (da) | Polyamin-derivater som antineoplastiske midler | |
DK544689D0 (da) | Terapeutisk aktive forbindelser | |
ATE247462T1 (de) | Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist | |
AU7935887A (en) | Therapeutic agent for the treatment of peptic ulcer disease | |
ES2117114T3 (es) | Nuevos derivados de tiaxolidin-diona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
AR022221A1 (es) | Composiciones que comprenden [(aminoiminometil)-amino]-alcanocarboxamidas en calidad de principio activo; [(aminoiminometil)-amino]-alcanocarboxamidas paraestas composiciones, y procedimiento para preparar dichas [(aminoiminometil)-amino]-alcanocarboxamidas | |
ES2160093A1 (es) | Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos. | |
ATE339204T1 (de) | Freisetzungsregulierende zubereitungen |